Symbol="CAPR"
AssetType="Common Stock"
Name="Capricor Therapeutics Inc"
Description="Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California."
CIK="1133869"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="8840 WILSHIRE BLVD, 2ND FLOOR, BEVERLY HILLS, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="152630000"
EBITDA="-29687230"
PERatio="None"
PEGRatio="0"
BookValue="0.246"
DividendPerShare="0"
DividendYield="0"
EPS="-1.16"
RevenuePerShareTTM="0.378"
ProfitMargin="0"
OperatingMarginTTM="-3.223"
ReturnOnAssetsTTM="-0.316"
ReturnOnEquityTTM="-1.878"
RevenueTTM="9455600"
GrossProfitTTM="1746400"
DilutedEPSTTM="-1.16"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="61.69"
PriceToBookRatio="6.5"
EVToRevenue="35.42"
EVToEBITDA="-2.043"
Beta="3.963"
num_52WeekHigh="6.68"
num_52WeekLow="3.3"
num_50DayMovingAverage="4.711"
num_200DayMovingAverage="4.39"
SharesOutstanding="25269900"
DividendDate="2019-06-05"
ExDividendDate="None"
symbol="CAPR"
open="5.98"
high="6.68"
low="5.95"
price="6.61"
volume="176469.00"
latest_trading_day="2023-08-14"
previous_close="6.04"
change="0.57"
change_percent="9.4371%"
aroon_positive_momentum_days="73"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="73"
Volume_recent_avg="72639"
Change_recent_avg="0.02"
Delta_recent_avg="0.21"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="0.32"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="73"
Aroon_momentum_negative="27"
image_negative_thumbnail_id_1="161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_negative_thumbnail_id_2="509"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="575"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_positive_thumbnail_id_1="645"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0063.jpeg"
image_positive_thumbnail_id_2="629"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0079.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
